IP-led pharma CDMO with GMP formulation and drug-delivery expertise
Rubicon Research is a 1,000+ person pharmaceutical development and manufacturing company operating GMP-certified R&D and manufacturing facilities in India and Canada. The company's hiring is heavily weighted toward manufacturing (77 roles), quality (51), and research (29), reflecting operational maturity rather than platform-building; active projects center on process validation, method transfer, and scale-up—tactical execution across a portfolio of 70+ products in development and 10+ under FDA review. Tech stack leans industrial (SAP, LIMS, SCADA, MES) with recent adoption of HR automation (SAP SuccessFactors, Workday, Oracle HCM Cloud), suggesting growing workforce complexity at scale.
Rubicon Research develops and manufactures pharmaceutical products and formulations across multiple dosage forms—oral solids, injectables, ophthalmics, nasals, topicals, and fixed-dose combinations—for generic and OTC markets. The company holds 50+ patents in drug-delivery technologies and operates a state-of-the-art GMP-certified R&D center in Thane, Maharashtra, supporting pre-formulation through pilot-scale manufacturing. The 2019 acquisition of Impopharma Canada expanded pulmonary and nasal drug-delivery capabilities. Rubicon serves as a CDMO and drug-development partner to pharmaceutical clients, with 28 approved products marketed in the US and a pipeline of 70+ in development or under regulatory review. The company operates across India and Canada with approximately 1,000–5,000 employees.
Enterprise systems include SAP, Tally, Oracle, and Microsoft 365. Lab and QC tools span HPLC, LC-MS/MS, GC-MS/MS, LIMS, and Chromeleon. Manufacturing integrates SCADA, PLC, HMI, and MES. Analytics via Power BI and Tableau. Currently adopting SAP SuccessFactors and Workday for HR automation.
Yes. 259 active roles posted across multiple departments: manufacturing (77), quality (51), research (29), operations (18), engineering (16), finance (11), regulatory (8), and HR (6). Hiring velocity is steady across India and Canada.
The company operates GMP-certified facilities for oral solids, oral liquids, topicals, sterile injectables, ophthalmics, and highly potent drug development (hormonal, oncology). Capabilities span pre-formulation studies through pilot-scale manufacturing in single integrated facilities.
Other companies in the same industry, closest in size